Episode 633: Could Intelligent Bio Solutions ($INBS) Be the Next Big Medtech Play?

As drug abuse rises globally, organizations and governments are turning to preventive solutions. With over 450 active accounts across 24 countries, Intelligent Bio Solutions (Nasdaq: INBS) is making a significant impact through its Intelligent Fingerprinting Drug Screening System. In this interview, Doug Heath, VP of Global Sales, and Anna Turkington, VP of Marketing, discuss how the company is advancing portable, rapid, and pain-free drug testing using its fingerprint-based screening technology. They also share insights into Intelligent Bio Solutions’ business model, growth outlook, market opportunity, and global expansion strategy. Find out more: https://ibs.inc/ Watch the full YouTube interview here: https://youtu.be/qHeVoWcBU_U And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1